Impact of Global Consensus Statement on compliance with hormonal therapy for surgical menopause

Objective: Initiation of and compliance with menopausal hormonal therapy (MHT) have been dropping due to the 2002 Women’s Health Initiative (WHI) publication. We evaluated the change in practice of MHT for surgical menopause after implementing the 2013 ‘Global Consensus Statement on MHT’ to our institutional guideline. Methods: A retrospective study was conducted in surgically menopausal women newly registering at the Siriraj Menopause Clinic in a university hospital, Thailand, from 1995 to 2013. The patients were categorized into four groups according to periods of MHT initiation: 1995–1998 (control), 2000–2003 (WHI affected), 2005–2008 (post WHI) and 2010–2013 (Global Consensus Statement affected). Their 3-year compliance with MHT was compared using forward stepwise regression analysis. Results: There were 288, 156, 107 and 104 cases in the 1995–1998, 2000–2003, 2005–2008 and 2010–2013 groups. Their mean age at surgery was 42.8 ± 4.7 years. After the first, second and third years, overall compliance was 82.4%, 70.9% and 61.2%, respectively. The 3-year compliance drastically dropped in the 2000–2003 group, and then improved to control level in the 2010–2013 group (51.9% vs. 77.9%, p = 0.035). Conclusion: The initiation of MHT continuously dropped during 2000–2013; however, compliance with MHT initiated during 2010–2013 improved after implementing the 2013 ‘Global Consensus Statement on MHT’ to our institutional guideline. Each institute should have a strategy to encourage the initiation of and compliance with MHT for surgical menopause to achieve long-term health benefits.